Compare Amulet Pharmaceuticals vs Ology Bioservices
Customers evaluate the quality of Amulet Pharmaceuticals's products using the following success metrics.
Overview
Amulet Pharmaceuticals is 23 yrs old and is based in United States.
Amulet Pharmaceuticals is a development stage medical device and therapeudics company where patented NORTECH „ technology aims to provide predictable and targeted time release of Nitric Oxide in the body.
Ology Bioservices is 25 yrs old and is based in United States.
Ology Bioservices is a privately held biopharmaceutical company with a major focus on developing a diversified proprietary pipeline of products having both biodefense and medical applications. Products under development include biodefense medical countermeasures, CNS, wound healing, addiction and pain, oncology, anti-infectives, vaccines and orthopedics. The Company has one FDA cleared injectable biologic, NanoFUSE DBM, used by orthopedic surgeons as bone graft filler. Nanotherapeutics has in-house cGMP manufacturing, formulation, and expertise in pre-clinical and clinical product development as well as clinical trial management to support its products. On April 12th, 2021, Ology Bioservices was acquired by RESILIENCE. The terms of the transaction were not disclosed.
Demo Video
Leadership
John Proch (Chief Financial Officer)
Brandon Brega (Chief Operating Officer)
Funding
Investors
Springboard Capital and Wilmington Investor Network
Resilience, U.S. Department of Defense
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Amulet Pharmaceuticals has not claimed their profile.
Work for Amulet Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Amulet Pharmaceuticals?
Claim your profile now.
Information not available because Ology Bioservices has not claimed their profile.
Work for Ology Bioservices? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Ology Bioservices?
Claim your profile now.